帕金森病发展的分子基础
Margarita Absalyamova1, Dmitrii Traktirov2, Viktoria Burdinskaya2
1Peter the Great St Petersburg Polytechnic University, Russia.
Neuroscience
|December 9, 2024
概括
帕金森病的神经退行包括氧化应激,炎症和蛋白质问题. 卡尔潘和截断的α-synuclein有助于帕金森病的聚合物形成和毒性.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 帕金森病是一种流行的神经退行性运动障碍,具有特定的运动症状.
- 虽然分子机制已被部分理解,但完整的病原发生原因仍不清楚.
- 神经退行的主要贡献者包括氧化应激,神经炎症和破坏细胞过程,如蛋白质稳定和自.
研究的目的:
- 审查导致帕金森病神经退行的各种因素.
- 为了阐明calpains在帕金森病病原发生中的作用.
- 要突出如何理解细胞过程可以告知治疗策略.
主要方法:
- 关于帕金森病病原学的当前概念的文献综述.
- 对氧化应激,神经炎症,蛋白质稳定,亡和自的作用的分析.
- 考察了calpains和α-synuclein之间的相互作用.
主要成果:
- 帕金森病中的神经退行是多因素的,涉及氧化应激,神经炎症和细胞功能受损.
- 卡尔帕因是一种依赖的蛋白酶家族,与这种疾病有关.
- 卡尔派的基质α-synuclein可以被截断,导致聚合物形成和毒性增加.
结论:
- 了解细胞因子的相互作用对于开发有效的帕金森病疗法至关重要.
- 卡尔帕因活性及其对α-synuclein处理的影响,是治疗干预的重要兴趣领域.
- 准这些分子通路可能会改善患者的生活质量.
关键词:
阿尔法同核蛋白是什么阿尔法同核蛋白卡尔佩恩斯 (Calpains) 是一个名为卡尔佩恩 (Calpains) 的公司.多巴氨基神经元是多巴氨基神经元.分子路径的分子路径.帕金森病是帕金森氏症的一种疾病.更多相关视频
相关概念视频
Parkinson's Disease: Overview
479
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479
Parkinson's Disease: Treatment
219
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
219
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
453
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
453
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Biological Causes of Schizophrenia
46
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
46


